Tony H. Wild

Founded in 2001 by Dr. Anthony Wild, James S. Burns and John T.W. Hawkins, MedPointe Capital Partners LLC is a private equity firm located in Somerset, New Jersey. The firm is known for having led a leveraged buyout of Carter-Wallace to form MedPointe Pharmaceuticals, Inc.

Fovea operates within the ophthalmic pharmaceutical market, which is expected to grow at a double-digit annual rate during the years to come. This growth is likely to be driven by new technologies and products, premium pricing facing no significant reimbursement issues, favorable trends (aging of the population, diabetes epidemiology and environmental factors) and dramatic expansion into the large and mostly untapped market for retinal degenerative diseases. With a limited number of players, the ophthalmology market has proved recently to be an early adopter of innovations, allowing new players to gain visibility very rapidly. During the last three years, Fovea has implemented this strategy, by acquiring products from large pharmaceutical or biotech companies and is actively developing them in four different indications. It has also integrated a unique drug discovery platform and has been able to identify one preclinical candidate and several interesting new targets.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

The American Chamber of Commerce in Japan is a Chamber of Commerce. The non-profit company is based in Minato-ku, Japan.

Slate Pharmaceuticals, Inc. develops and researches on products for diseases of maturing men and women. It focuses on hormonal products for the treatment of andropause and menopause. The company was founded in 2007 by Robert S. Whitehead and is headquartered in Durham, NC

Innocoll, Inc. developed and manufactured pharmaceutical products and medical devices. The company was headquartered in Ashburn, VA.

BOWS Pharmaceuticals AG operates as a biotechnology firm. The company is headquartered in Zug, Switzerland.

Sprout Pharmaceuticals, Inc. provides delivery of a treatment option for the unmet need of women with Hypoactive Sexual Desire Disorder. The company was founded by Cynthia E. Whitehead and Robert S. Whitehead on November 29, 2011 and is headquartered in Raleigh, NC.

Innocoll AG engages in the engineering, manufacture, sale of collagen-based products for post-surgical applications. Its pipeline products include bupivacaine-collagen bioresorbable implant, gentamicin-collagen topical matrix, and bioresorbable collagen film surgical adhesion barrier. The company was founded in December 1997 and is headquartered in Athlone, Ireland.

Sermonix Pharmaceuticals LLC operates as a pharmaceutical company that focuses on the development and commercialization of late-stage women?s health products. It offers lasofoxifene, a selective estrogen receptor modulator for the treatment of vulvovaginal atrophy, as well as treatment and prevention of post-menopausal osteoporosis. The company was founded in 2014 by David Portman and is headquartered in Columbus, OH.